Bio-Rad Labs (BIO) Reports Q4 EPS of $1.68
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $381.68 +1.81%
Revenue Growth %: -0.5%
Financial Fact:
Other (income) expense, net: -11.21M
Today's EPS Names:
ATS, SICP, FTCO, More
Revenue Growth %: -0.5%
Financial Fact:
Other (income) expense, net: -11.21M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q4 EPS of $1.68, does not compare to the analyst estimate of $1.27. Revenue for the quarter came in at $570.6 million versus the consensus estimate of $570.8 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- Intel shares fall as competitor reports record results
- RxSight Inc. (RXST) PT Lowered to $5 at Stifel
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
